## **Core Concept**
The Multiple Endocrine Neoplasia Type 1 (MEN-I) syndrome is a rare hereditary disorder characterized by the occurrence of tumors in multiple endocrine glands. It primarily affects the **parathyroid glands**, the **pancreas**, and the **pituitary gland**. The syndrome is associated with various endocrine tumors due to mutations in the MEN1 gene.

## **Why the Correct Answer is Right**
The correct answer, **Parathyroid tumor (or hyperparathyroidism)**, is the most common feature of MEN-I, occurring in approximately 90-95% of patients. This high prevalence is due to the fact that mutations in the MEN1 gene lead to the inactivation of a tumor suppressor protein, which normally helps regulate cell growth. The parathyroid glands are particularly sensitive to this loss of regulation, leading to hyperparathyroidism.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While **pituitary adenomas** are indeed associated with MEN-I, they occur less frequently than parathyroid tumors, affecting about 30-40% of patients.
- **Option B:** **Pancreatic neuroendocrine tumors (PNETs)** are also a component of MEN-I but are less common than parathyroid tumors, occurring in approximately 30-80% of patients, depending on the series.
- **Option D:** **Adrenal tumors** are not typically considered a primary feature of MEN-I. While adrenal incidentalomas may occur, they are not as strongly associated with MEN-I as the other options.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl for MEN-I is the "3 Ps": **Parathyroid**, **Pancreas**, and **Pituitary**. Remembering these organs helps in identifying patients with MEN-I. Screening for MEN-I involves checking for hypercalcemia (parathyroid), evaluating pancreatic imaging (for neuroendocrine tumors), and assessing for pituitary abnormalities.

## **Correct Answer:** B. Parathyroid tumor.